Rob E. Aarnoutse
Impact in
- Infectious Diseases top 0.1%
- Tuberculosis Research and Epidemiology
- HIV/AIDS drug development and treatment
- Pharmacology top 0.5%
- Antibiotics Pharmacokinetics and Efficacy
- Drug-Induced Hepatotoxicity and Protection
Papers in
-
- Tuberculosis Research and Epidemiology 69
- HIV/AIDS drug development and treatment 30
- HIV/AIDS Research and Interventions 11
- Epidemiology 59
- Pneumocystis jirovecii pneumonia detection and treatment 26
- Mycobacterium research and diagnosis 22
- Co-authors
- Martin J. Boeree (51 shared papers)David M. Burger (47 shared papers)Reinout van Crevel (30 shared papers)Rovina Ruslami (31 shared papers)André van der Ven (7 shared papers)Bachti Alisjahbana (8 shared papers)Alma Tostmann (7 shared papers)Gibson Kibiki (18 shared papers)
- Journals
- Antimicrobial Agents and Chemotherapy (24 papers)Journal of Antimicrobial Chemotherapy (16 papers)International Journal of Antimicrobial Agents (13 papers)Therapeutic Drug Monitoring (9 papers)Clinical Infectious Diseases (9 papers)
- Partner nations
- NetherlandsUnited StatesIndonesia
In The Last Decade
Rob E. Aarnoutse
189 papers receiving 6.7k citations
Rob E. Aarnoutse's Hit Papers
Peers
Comparison fields: 5 of 134
- Infectious Diseases 4.0k
- Pharmacology 689
- Virology 345
- Epidemiology 2.1k
- Pharmacology 770
Countries citing papers authored by Rob E. Aarnoutse
This map shows the geographic impact of Rob E. Aarnoutse's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rob E. Aarnoutse with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rob E. Aarnoutse more than expected).
Fields of papers citing papers by Rob E. Aarnoutse
This network shows the impact of papers produced by Rob E. Aarnoutse. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rob E. Aarnoutse. The network helps show where Rob E. Aarnoutse may publish in the future.
Co-authors
The 25 scholars most cited alongside Rob E. Aarnoutse, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 198 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Antituberculosis drug‐induced hepatotoxicity: Concise up‐to‐date review Hit paper breakdown → | 2007 | 599 |
| 2 | 2012 | 255 | |
| 3 | 2015 | 228 | |
| 4 | 2008 | 210 | |
| 5 | 2006 | 186 | |
| 6 | 2010 | 182 | |
| 7 | 2012 | 158 | |
| 8 | 2007 | 152 | |
| 9 | 2014 | 152 | |
| 10 | 2007 | 139 | |
| 11 | 2003 | 137 | |
| 12 | 2003 | 127 | |
| 13 | 2008 | 103 | |
| 14 | 2009 | 96 | |
| 15 | 2016 | 91 | |
| 16 | 2003 | 85 | |
| 17 | 2017 | 83 | |
| 18 | 2009 | 82 | |
| 19 | 2013 | 80 | |
| 20 | 2008 | 80 |
About Rob E. Aarnoutse
Rob E. Aarnoutse is a scholar working on Infectious Diseases, Epidemiology, Pharmacology, Surgery and Oncology, having authored 198 papers that have together received 7.0k indexed citations. Recurring topics across this work include Tuberculosis Research and Epidemiology (69 papers), HIV/AIDS drug development and treatment (30 papers), Antibiotics Pharmacokinetics and Efficacy (26 papers), Pneumocystis jirovecii pneumonia detection and treatment (26 papers), Mycobacterium research and diagnosis (22 papers), Infectious Diseases and Tuberculosis (17 papers), Drug Transport and Resistance Mechanisms (16 papers) and HIV/AIDS Research and Interventions (11 papers). The work is most often cited by research in Infectious Diseases (4.0k citations), Pharmacology (689 citations), Virology (345 citations), Epidemiology (2.1k citations) and Pharmacology (770 citations). Rob E. Aarnoutse has collaborated with scholars based in Netherlands, United States and Indonesia. Frequent co-authors include Martin J. Boeree, David M. Burger, Reinout van Crevel, Rovina Ruslami, André van der Ven, Bachti Alisjahbana, Alma Tostmann, Gibson Kibiki, Roger J. M. Brüggemann and Wiel C.M. de Lange. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Journal of Antimicrobial Chemotherapy, International Journal of Antimicrobial Agents, Therapeutic Drug Monitoring and Clinical Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.